GSK Plc announced a share buyback of £2 billion as it saw better than expected profit in the fourth quarter. The share ...
GSK forecast sales in 2025 to grow 3%-5% and reported better-than-expected fourth-quarter earnings, as strength in its HIV ...
The pharmaceutical giant targets an increase in core operating profit of between 6% and 8% in 2025, after cancer treatments ...
The pharmaceutical company citied promising pipeline developments and said cancer treatments drove above-expected growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback